ARCHIVES

Prevention Program Being Developed For Primary Providers

This article is from The Cancer Letter archive.

Vol. 14 No. 05 | January 29, 1988

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

NCI’s Breast Cancer Screening Guidelines Released In Draft

September 24, 1993

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

DCPC Board Objects To Cutting Grants Each Award Year

February 17, 1989

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President

November 25, 1994